Cognitive deficits predict low treatment retention in cocaine dependent patients E Aharonovich, DS Hasin, AC Brooks, X Liu, A Bisaga, EV Nunes Drug and alcohol dependence 81 (3), 313-322, 2006 | 554 | 2006 |
Development of a cascade of care for responding to the opioid epidemic AR Williams, EV Nunes, A Bisaga, FR Levin, M Olfson The American journal of drug and alcohol abuse 45 (1), 1-10, 2019 | 307 | 2019 |
Cerebral glucose metabolism in women with panic disorder A Bisaga, JL Katz, A Antonini, CE Wright, C Margouleff, JM Gorman, ... American Journal of Psychiatry 155 (9), 1178-1183, 1998 | 199 | 1998 |
The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans A Bisaga, SD Comer, AS Ward, P Popik, HD Kleber, MW Fischman Psychopharmacology 157, 1-10, 2001 | 182 | 2001 |
Cognition, commitment language, and behavioral change among cocaine-dependent patients. E Aharonovich, PC Amrhein, A Bisaga, EV Nunes, DS Hasin Psychology of Addictive Behaviors 22 (4), 557, 2008 | 177 | 2008 |
Developing an opioid use disorder treatment cascade: A review of quality measures AR Williams, EV Nunes, A Bisaga, HA Pincus, KA Johnson, AN Campbell, ... Journal of substance abuse treatment 91, 57-68, 2018 | 172 | 2018 |
Sex differences and hormonal influences on response to cold pressor pain in humans WJ Kowalczyk, SM Evans, AM Bisaga, MA Sullivan, SD Comer The Journal of Pain 7 (3), 151-160, 2006 | 172 | 2006 |
In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists A Bisaga, P Popik Drug and alcohol dependence 59 (1), 1-15, 2000 | 161 | 2000 |
Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice SC Sigmon, A Bisaga, EV Nunes, PG O'Connor, T Kosten, G Woody The American journal of drug and alcohol abuse 38 (3), 187-199, 2012 | 150 | 2012 |
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis VS Tardelli, A Bisaga, FB Arcadepani, G Gerra, FR Levin, TM Fidalgo Psychopharmacology 237 (8), 2233-2255, 2020 | 132 | 2020 |
Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial FR Levin, JJ Mariani, M Pavlicova, D Brooks, A Glass, A Mahony, ... Drug and alcohol dependence 159, 53-60, 2016 | 113 | 2016 |
Long-acting injectable naltrexone induction: a randomized trial of outpatient opioid detoxification with naltrexone versus buprenorphine M Sullivan, A Bisaga, M Pavlicova, CJ Choi, K Mishlen, KM Carpenter, ... American Journal of Psychiatry 174 (5), 459-467, 2017 | 112 | 2017 |
A randomized double‐blind, placebo‐controlled trial of venlafaxine‐extended release for co‐occurring cannabis dependence and depressive disorders FR Levin, J Mariani, DJ Brooks, M Pavlicova, EV Nunes, V Agosti, ... Addiction 108 (6), 1084-1094, 2013 | 109 | 2013 |
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone A Bisaga, MA Sullivan, A Glass, K Mishlen, M Pavlicova, M Haney, ... Drug and alcohol dependence 154, 38-45, 2015 | 108 | 2015 |
Interaction between naltrexone and oral THC in heavy marijuana smokers M Haney, A Bisaga, RW Foltin Psychopharmacology 166, 77-85, 2003 | 108 | 2003 |
A randomized placebo-controlled trial of gabapentin for cocaine dependence A Bisaga, E Aharonovich, F Garawi, FR Levin, E Rubin, WN Raby, ... Drug and Alcohol Dependence 81 (3), 267-274, 2006 | 102 | 2006 |
Acute interaction of baclofen in combination with alcohol in heavy social drinkers SM Evans, A Bisaga Alcoholism: clinical and experimental research 33 (1), 19-30, 2009 | 99 | 2009 |
Acute effects of memantine in combination with alcohol in moderate drinkers A Bisaga, SM Evans Psychopharmacology 172, 16-24, 2004 | 99 | 2004 |
Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial JJ Mariani, M Pavlicova, A Bisaga, EV Nunes, DJ Brooks, FR Levin Biological psychiatry 72 (11), 950-956, 2012 | 97 | 2012 |
A randomized trial comparing extended-release injectable suspension and oral naltrexone, both combined with behavioral therapy, for the treatment of opioid use disorder MA Sullivan, A Bisaga, M Pavlicova, KM Carpenter, CJ Choi, K Mishlen, ... American Journal of Psychiatry 176 (2), 129-137, 2019 | 96 | 2019 |